Free Trial

Recursion Pharmaceuticals (RXRX) Insider Trading & Ownership

Recursion Pharmaceuticals logo
$6.91 -0.41 (-5.60%)
(As of 11/14/2024 ET)

Recursion Pharmaceuticals (NASDAQ:RXRX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
15.75%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
8
Amount Of
Insider Selling
(Last 12 Months)
$10.25 M
Get RXRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Recursion Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

RXRX Insider Buying and Selling by Quarter

Recursion Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/29/2024Blake BorgesonDirectorSell11,447$6.72$76,923.84  
10/24/2024Tina MarriottCOOSell6,000$6.31$37,860.00  
10/15/2024Blake BorgesonDirectorSell11,447$6.67$76,351.49  
10/8/2024Michael SecoraCFOSell15,000$6.32$94,800.00  
10/2/2024Christopher GibsonCEOSell20,000$6.16$123,200.00  
10/1/2024Blake BorgesonDirectorSell11,447$6.22$71,200.34  
9/26/2024Tina MarriottCOOSell6,000$7.00$42,000.00  
9/17/2024Blake BorgesonDirectorSell11,447$6.84$78,297.48  
9/10/2024Michael SecoraCFOSell15,000$6.17$92,550.00  
9/4/2024Christopher GibsonCEOSell20,000$6.04$120,800.00  
9/3/2024Blake BorgesonDirectorSell11,447$6.27$71,772.69  
8/29/2024Tina MarriottCOOSell6,000$7.56$45,360.00  
8/20/2024Blake BorgesonDirectorSell11,447$7.12$81,502.64  
8/13/2024Michael SecoraCFOSell15,000$6.35$95,250.00  
8/7/2024Christopher GibsonCEOSell30,000$7.10$213,000.00  
8/6/2024Blake BorgesonDirectorSell11,447$6.82$78,068.54  
7/25/2024Tina MarriottCOOSell6,000$8.13$48,780.00  
7/23/2024Blake BorgesonDirectorSell11,447$8.48$97,070.56  
7/10/2024Christopher GibsonCEOSell50,000$7.48$374,000.00  
7/9/2024Blake BorgesonDirectorSell11,447$7.32$83,792.04  
7/9/2024Michael SecoraCFOSell15,000$7.32$109,800.00  
6/27/2024Tina MarriottCOOSell6,000$7.21$43,260.00  
6/25/2024Blake BorgesonDirectorSell11,447$9.51$108,860.97  
6/13/2024Michael SecoraCFOSell15,000$9.32$139,800.00  
6/11/2024Blake BorgesonDirectorSell11,447$8.45$96,727.15  
6/5/2024Christopher GibsonCEOSell50,000$8.42$421,000.00  
5/30/2024Tina MarriottCOOSell3,000$8.78$26,340.00  
5/28/2024Blake BorgesonDirectorSell11,447$9.17$104,968.99  
5/1/2024Christopher GibsonCEOSell50,000$7.73$386,500.00  
4/30/2024Blake BorgesonDirectorSell11,447$7.95$91,003.65  
4/25/2024Tina MarriottCOOSell3,000$7.67$23,010.00  
4/17/2024Michael SecoraCFOSell23,124$7.58$175,279.92  
4/16/2024Blake BorgesonDirectorSell11,447$7.66$87,684.02  
4/3/2024Christopher GibsonCEOSell40,000$8.84$353,600.00  
4/2/2024Blake BorgesonDirectorSell11,447$8.82$100,962.54  
3/28/2024Christopher GibsonCEOSell40,000$10.10$404,000.00  
3/21/2024Tina MarriottCOOSell8,000$10.75$86,000.00  
3/19/2024Blake BorgesonDirectorSell20,054$10.79$216,382.66  
3/13/2024Michael SecoraCFOSell25,000$11.03$275,750.00  
3/6/2024Christopher GibsonCEOSell36,319$11.86$430,743.34  
The next assassination attempt won’t be on Trump (Ad)

President Trump is soon to be back in the White House. Unity has been restored to the U.S. But if you watched the President’s 25-minute victory speech, you probably noticed he spent nearly four minutes speaking about one very controversial person.

I share with you in this special investigative documentary.
3/5/2024Blake BorgesonDirectorSell20,054$12.06$241,851.24  
2/22/2024Tina MarriottCOOSell8,000$14.89$119,120.00  
2/20/2024Blake BorgesonDirectorSell20,054$12.32$247,065.28  
2/13/2024Michael SecoraCFOSell25,000$9.86$246,500.00  
2/7/2024Christopher GibsonCEOSell48,272$9.22$445,067.84  
2/6/2024Blake BorgesonDirectorSell11,447$9.30$106,457.10  
1/25/2024Tina Marriott LarsonCOOSell8,000$10.35$82,800.00  
1/23/2024Blake BorgesonDirectorSell20,054$10.58$212,171.32  
1/16/2024Michael SecoraCFOSell25,000$10.45$261,250.00  
1/16/2024Shafique ViraniInsiderSell18,000$10.93$196,740.00  
1/9/2024Dean Y LiDirectorSell29,000$13.66$396,140.00  
1/3/2024Christopher GibsonCEOSell30,853$9.49$292,794.97  
12/26/2023Blake BorgesonDirectorSell20,054$10.63$213,174.02  
12/15/2023Shafique ViraniInsiderSell18,000$9.60$172,800.00  
12/14/2023Zavain DarDirectorSell20,141$9.00$181,269.00  
12/12/2023Blake BorgesonDirectorSell11,447$7.40$84,707.80  
12/12/2023Michael SecoraCFOSell25,000$7.39$184,750.00  
12/6/2023Christopher GibsonCEOSell59,829$7.49$448,119.21  
11/28/2023Blake BorgesonDirectorSell11,447$6.72$76,923.84  
11/16/2023Tina Marriott LarsonCOOSell3,000$6.76$20,280.00  
11/15/2023Shafique ViraniInsiderSell18,000$6.51$117,180.00  
11/14/2023Blake BorgesonDirectorSell8,885$6.32$56,153.20  
11/14/2023Michael SecoraCFOSell25,000$6.32$158,000.00  
(Data available from 1/1/2013 forward)

RXRX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Recursion Pharmaceuticals includes Blake Borgeson, Christopher Gibson, Dean Y Li, Michael Secora, Mubadala Investment Co Pjsc, Shafique Virani, Terry-Ann Burrell, Tina Marriott, Tina Marriott Larson, and Zavain Dar. Learn more on insiders at RXRX.

15.75% of Recursion Pharmaceuticals stock is owned by insiders. Learn more on RXRX's insider holdings.

The following insider purchased RXRX shares in the last 24 months: Mubadala Investment Co Pjsc ($4,440,853.30).

Insiders have purchased a total of 581,017 RXRX shares in the last 24 months for a total of $4,440,853.30 bought.

The following insiders have sold RXRX shares in the last 24 months: Blake Borgeson ($5,000,727.14), Christopher Gibson ($8,145,291.57), Dean Y Li ($396,140.00), Michael Secora ($3,039,229.92), Shafique Virani ($2,142,358.38), Terry-Ann Burrell ($104,182.25), Tina Marriott ($471,730.00), Tina Marriott Larson ($690,510.00), and Zavain Dar ($181,269.00).

Insiders have sold a total of 2,274,334 Recursion Pharmaceuticals shares in the last 24 months for a total of $20,171,438.26 sold.

Recursion Pharmaceuticals Key Executives

  • Dr. Christopher C. Gibson Ph.D. (Age 41)
    Co-Founder, CEO & Director
    Compensation: $806.72k
  • Ms. Tina Marriott LarsonMs. Tina Marriott Larson (Age 49)
    COO & President
    Compensation: $702.24k
  • Dr. Blake C. Borgeson Ph.D. (Age 42)
    Co-Founder & Director
    Compensation: $40k
  • Dr. Michael Secora Ph.D. (Age 41)
    Chief Financial Officer
    Compensation: $629.78k
  • Dr. David J. Mauro M.D. (Age 59)
    Ph.D., Chief Medical Officer
    Compensation: $674.74k
  • Kevin Leggat
    Vice President of Finance & Accounting
  • Mr. Benjamin Mabey M.S. (Age 41)
    Chief Technology Officer
  • Mr. Jared Allenbach
    Senior Director of Investor Relations
  • Mr. Nathan Hatfield
    Chief Legal Officer & General Counsel
  • Mr. Ryan Kelly
    Chief Communications Officer


This page (NASDAQ:RXRX) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners